Observational studyBMC endocrine disorders2015

Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.

Shinichi Umezawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.